Skip to content
Sheldon DengYue 1 year ago
sheldon-dengyue

Flyrcado : A Breakthrough In Cardiac PET Imaging For Coronary Artery Disease

In a landmark advancement for nuclear cardiology, GE HealthCare has launched Flyrcado™ (flurpiridaz F 18), the first FDA-approved unit-dose positron emission tomography (PET) myocardial perfusion imaging (MPI) agent for detecting coronary artery disease (CAD). Approved in September 2024 and commercially available in select U.S. markets since early 2025, Flyrcado promises higher diagnostic accuracy, broader accessibility, and enhanced clinical flexibility compared to traditional SPECT MPI. This innovation marks the first new cardiac perfusion tracer in nearly 30 years, addressing long-standing limitations in cardiac imaging. With its 109-minute half-life—ten times longer than conventional PET tracers—Flyrcado enables centralized production and nationwide distribution, eliminating the need for on-site cyclotrons and expanding access to community hospitals and smaller healthcare systems. More details at : https://dengyuemed.com/news/flyrcado-a-breakthrough-in-cardiac-pet-imaging/

0
122

Questions on Office Flowers What size and style of office flowers is b...

saiflower
3 minutes ago

Belt and Brush Deburring Processes on a Flat Deburring Machine

Deburring on a flat deburring machine is built around the contact between a moving tooling...

johnmin ren
23 minutes ago

Selecting a Flat Deburring Machine for Burr Height and Edge Radius Con...

When a sheet metal part is specified for a functional assembly, the dimensional tolerance...

johnmin ren
24 minutes ago

Flat Deburring Machine Fundamentals for Precision Sheet Metal Fabricat...

In precision sheet metal fabrication, the cut edge is never really finished the moment the...

johnmin ren
24 minutes ago
Best Chauffeur Service London for Exploring the City in Comfort

Best Chauffeur Service London for Exploring the City in Comfort

Heathrow Carrier
26 minutes ago
BangBox Online homepage